Howard Fillit, MD

Articles by Howard Fillit, MD

Navigating the Alzheimer Disease Blood Test Revolution

ByMaggie L. Shaw,Howard Fillit, MD,Anthony "Nino" Sireci, MD, MSc

September 9th 2025

A new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.

The Pharmacoeconomics of Alzheimer's Disease

ByHoward Fillit, MD

December 1st 2000

Managed Care Decisions in Alzheimer's Disease

ByHoward Fillit, MD

December 1st 2000

Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication Reviews

ByHoward Fillit, MD,Robert Futterman, PhD,Burton I. Orland, RPh,Terrence Chim, RPh,Lawrence Susnow, MD,Gloria Picariello, RN,Eileen C. S

May 1st 1999

Opportunities for Improving Managed Care for Individuals with Dementia: Part I - The Issues

ByHoward Fillit, MD,David Knopman, MD,Jeffrey Cummings, MD,Frank Appel, MS,for the Alzheimer's Disease Managed Care Advisory Council

March 1st 1999

Opportunities for Improving Managed Care for Individuals with Dementia: Part II - A Framework for Care

ByHoward Fillit, MD,David Knopman, MD,Jeffrey Cummings, MD,Frank Appel, MS,for the Alzheimer's Disease Managed Care Advisory Council

March 1st 1999

Use of Ineffective or Unsafe Medications Among Members of a Medicare HMO Compared to Individuals in a Medicare Fee-for-Service Program

ByRobert Futterman, PhD,Howard Fillit, MD,John L. Rogleri, MD

April 1st 1997

Howard Fillit, MD

Articles by Howard Fillit, MD

Navigating the Alzheimer Disease Blood Test Revolution

The Pharmacoeconomics of Alzheimer's Disease

Managed Care Decisions in Alzheimer's Disease

Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication Reviews

Opportunities for Improving Managed Care for Individuals with Dementia: Part I - The Issues

Opportunities for Improving Managed Care for Individuals with Dementia: Part II - A Framework for Care

Use of Ineffective or Unsafe Medications Among Members of a Medicare HMO Compared to Individuals in a Medicare Fee-for-Service Program

Latest Updated Articles

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”

Monoclonal Antibodies Had Varying Efficacy in Treating MG